Robert Haemmerle

ORCID: 0000-0003-0139-9706
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Neutropenia and Cancer Infections
  • Economic and Financial Impacts of Cancer
  • Cancer survivorship and care
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Treatments and Mutations
  • Advanced Causal Inference Techniques
  • Mobile Health and mHealth Applications
  • Nutrition and Health in Aging
  • Adolescent and Pediatric Healthcare
  • Cancer-related cognitive impairment studies
  • Tuberculosis Research and Epidemiology
  • Health Systems, Economic Evaluations, Quality of Life
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Metabolism, Diabetes, and Cancer
  • Cancer Risks and Factors
  • Homelessness and Social Issues
  • Frailty in Older Adults
  • Streptococcal Infections and Treatments
  • Housing, Finance, and Neoliberalism
  • AI in cancer detection
  • Diet and metabolism studies
  • Antimicrobial Resistance in Staphylococcus
  • Infective Endocarditis Diagnosis and Management
  • Childhood Cancer Survivors' Quality of Life

Mayo Clinic in Arizona
2023-2025

Mayo Clinic
2024

Background: Patients who experience homelessness manifest poor cancer outcomes, often because of treatment delays. Few studies have used mixed methods to learn what happens at the patient and health care staff level explain these Methods: This single-institution, multi-site study interrogated entire medical record system (thousands patients annually) for diagnoses from January 1, 2019, through October 10, 2023. Records were abstracted relevant quantitative qualitative data; rigorous analyze,...

10.1177/10499091251325231 article EN American Journal of Hospice and Palliative Medicine® 2025-03-18

572 Background: The DEFeNDR (Decreasing the burden of Febrile Neutropenia through Dynamic RPM) program leverages in-home technology and centralized nurse monitoring to facilitate ambulatory management as an alternative hospital-based care for cancer patients with neutropenic fever (NF). objective this study is assess 30-day utilization outcomes patient satisfaction at 12 months after implementation. Methods: Adult hospitalized NF were assessed daily eligibility including MASCC score ≥21 (per...

10.1200/op.2023.19.11_suppl.572 article EN JCO Oncology Practice 2023-10-26

1535 Background: Ambulatory management of select patients with febrile neutropenia (FN) may substantially decrease patients’ burden illness and improve their quality life, is recommended by American Society Clinical Oncology (ASCO) guidelines. However, in the United States, inpatient remains universal standard. We hereby report health care utilization associated DEFeNDR remote patient monitoring (RPM) program, which leverages technology virtual centralized nurse to facilitate ambulatory FN...

10.1200/jco.2023.41.16_suppl.1535 article EN Journal of Clinical Oncology 2023-06-01

This case report describes Osler nodes and Janeway lesions on a man in his 70s.

10.1001/jamadermatol.2024.0481 article EN JAMA Dermatology 2024-04-03

e16368 Background: Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second cause of cancer death in US by 2040. For minority patients who are candidates for curative-intent surgical resection, a neoadjuvant approach with chemotherapy or followed chemoradiotherapy (chemoRT) has become standard care. The tumor microenvironment (TME) been recognized as key factor therapeutic resistance and disease progression. This study aims explore prognostic value human-interpretable machine...

10.1200/jco.2024.42.16_suppl.e16368 article EN Journal of Clinical Oncology 2024-06-01

1552 Background: Immune checkpoint inhibitor therapy-related (ICI) pneumonitis poses a significant challenge in patients with cancer. There is need for predictive modeling to identify those at high risk of developing serious adverse events ICI pneumonitis. Methods: A newly created database cancer diagnosed seen Mayo Clinic from 2014-2022 was utilized exploratory data analysis. Modeling used determine if three clinical outcomes could be predicted, namely death from: prior starting...

10.1200/jco.2023.41.16_suppl.1552 article EN Journal of Clinical Oncology 2023-06-01

<h3>Background</h3> Immune checkpoint inhibitor therapy-related (ICI) pneumonitis is a potential serious complication for patients with cancer. We have previously shown that modeling can be used to predict the risk of death from ICI pneumonitis.<sup>1</sup> Further predictive stratify needed. <h3>Methods</h3> A database cancer diagnosed seen at Mayo Clinic 2014–2022 was utilized exploratory data analysis. Within this cohort, we isolated clinical variables before diagnoses determine if could...

10.1136/jitc-2023-sitc2023.1266 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2023-10-31

Patients with cancer or a history of often seek nutritional advice. In turn, health care providers are asked questions related to nutrition and cancer. Should I take high-dose vitamins other supplements? regular-dose vitamin Will experience weight loss during postoperative chemotherapy? What should be my goals after adjuvant therapy? the setting advanced cancer, what do keep appetite up? This review attempts provide data-driven answers some these commonly posed questions.

10.1200/op.23.00480 article EN JCO Oncology Practice 2023-12-21

<h3>Background</h3> Immune checkpoint inhibitor therapy-related (ICI) pneumonitis poses a significant challenge in patients with cancer. There is paucity of data on patient characteristics and outcomes this population. <h3>Methods</h3> This retrospective study diagnosed ICI at the Mayo Clinic from 2014 to 2022. A list was compiled using Clinic's informatics tool, Advanced Text Explorer, keywords 'pneumonitis' 'immunotherapy' (n=848). All cases were independently reviewed by our pulmonology...

10.1136/jitc-2023-sitc2023.1265 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2023-10-31
Coming Soon ...